Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Immunogen Inc (IMGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 803,595
  • Shares Outstanding, K 149,090
  • Annual Sales, $ 115,450 K
  • Annual Income, $ -96,010 K
  • 36-Month Beta 2.56
  • Price/Sales 7.01
  • Price/Cash Flow N/A
  • Price/Book 17.17

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.33
  • Number of Estimates 8
  • High Estimate -0.30
  • Low Estimate -0.36
  • Prior Year -0.10
  • Growth Rate Est. (year over year) -230.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.11 +5.48%
on 12/10/18
6.03 -10.61%
on 11/16/18
-0.19 (-3.41%)
since 11/13/18
3-Month
5.11 +5.48%
on 12/10/18
9.84 -45.22%
on 10/03/18
-3.87 (-41.79%)
since 09/13/18
52-Week
5.11 +5.48%
on 12/10/18
13.41 -59.81%
on 03/26/18
-1.40 (-20.62%)
since 12/13/17

Most Recent Stories

More News
Watch for Immunogen Inc to Potentially Pullback After Gaining 4.63% Yesterday

Immunogen Inc (NASDAQ:IMGN) traded in a range yesterday that spanned from a low of $5.47 to a high of $5.82. Yesterday, the shares gained 4.6%, which took the trading range above the 3-day high of $5.60...

IMGN : 5.39 (-0.74%)
Market Trends Toward New Normal in Marriott International, Duke Energy, ImmunoGen, Newell Brands, Vail Resorts, and Fiserv -- Emerging Consolidated Expectations, Analyst Ratings

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Marriott International (NASDAQ:MAR),...

NWL : 22.78 (-3.31%)
MTN : 221.27 (-1.68%)
FISV : 77.74 (+0.13%)
IMGN : 5.39 (-0.74%)
DUK : 90.90 (+1.45%)
MAR : 108.85 (-1.11%)
Immunogen Inc Down 33.1% Since SmarTrend Downtrend Call (IMGN)

SmarTrend identified a Downtrend for Immunogen Inc (NASDAQ:IMGN) on October 5th, 2018 at $8.23. In approximately 2 months, Immunogen Inc has returned 33.13% as of today's recent price of $5.50.

IMGN : 5.39 (-0.74%)
Roche's Kadcyla Halves Death Risk in Breast Cancer Study

Roche (RHHBY) announces detailed data from a late-stage study on Kadcyla in early breast cancer patients. Kadcyla reduces risk of disease recurrence by 50% compared to Herceptin.

IMGN : 5.39 (-0.74%)
NVS : 88.40 (+0.31%)
TEVA : 19.02 (+0.16%)
RHHBY : 31.9000 (-1.12%)
Shares of IMGN Down 30.3% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Immunogen Inc (NASDAQ:IMGN) on October 5th, 2018 at $8.23. In approximately 2 months, Immunogen Inc has returned 30.27% as of today's recent price of $5.74.

IMGN : 5.39 (-0.74%)
ImmunoGen (IMGN) Down 7.2% Since Last Earnings Report: Can It Rebound?

ImmunoGen (IMGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

IMGN : 5.39 (-0.74%)
ImmunoGen Presents New Data Highlighting Potential of Novel ADCs in Oral Presentations at ASH Annual Meeting

--Maturing Data for CD33-Targeting IMGN779 Reflect Consistent Activity and Tolerability Profile in AML; Dose Exploration Continues

IMGN : 5.39 (-0.74%)
ImmunoGen Announces Resignation of Chief Financial Officer

ImmunoGen, Inc., (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that David B. Johnston has stepped...

IMGN : 5.39 (-0.74%)
Are Options Traders Betting on a Big Move in ImmunoGen (IMGN) Stock?

Investors need to pay close attention to ImmunoGen (IMGN) stock based on the movements in the options market lately.

IMGN : 5.39 (-0.74%)
Immunogen Inc Has Returned 32.5% Since SmarTrend Recommendation (IMGN)

SmarTrend identified a Downtrend for Immunogen Inc (NASDAQ:IMGN) on October 5th, 2018 at $8.23. In approximately 1 month, Immunogen Inc has returned 32.52% as of today's recent price of $5.55.

IMGN : 5.39 (-0.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade IMGN with:

Business Summary

ImmunoGen, Inc. develops pharmaceuticals, primarily for the treatment of cancer. The company's product candidates are called tumor-activated prodrugs and are based on its proprietary immunoconjugate technology platform. Unlike conventional chemotherapeutic agents, tumor-activated prodrugs are intended...

See More

Key Turning Points

2nd Resistance Point 5.66
1st Resistance Point 5.52
Last Price 5.39
1st Support Level 5.28
2nd Support Level 5.18

See More

52-Week High 13.41
Fibonacci 61.8% 10.24
Fibonacci 50% 9.26
Fibonacci 38.2% 8.28
Last Price 5.39
52-Week Low 5.11

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar